Paper39636147
Diversity in chemotherapy-induced cachexia.
Novinger LJ and 2 others. Am J Physiol Cell Physiol, 2025. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Diversity in chemotherapy-induced cachexia. Papers, record 39636147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39636147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Cachexia | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Female | |
| Humans | |
| Male | |
| Age Factors | |
| Muscle, Skeletal | |
| Muscular Atrophy | |
| Sex Factors |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AR080051 | NIAMS NIH HHS | United States | R01AR080051 | PubMed and NIH | NIH RePORTER |
| P50 CA261605 | NCI NIH HHS | United States | P50CA261605 | PubMed and NIH | NIH RePORTER |
| R01 AR079379 | NIAMS NIH HHS | United States | R01AR079379 | PubMed and NIH | NIH RePORTER |
| R01AR080051 | HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | R01AR080051 | PubMed and NIH | NIH RePORTER | |
| P50CA261605 | HHS | NIH | National Cancer Institute (NCI) | P50CA261605 | PubMed and NIH | NIH RePORTER | |
| R01AR079379 | HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | R01AR079379 | PubMed and NIH | NIH RePORTER |
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30144305 | Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients. | J Cachexia Sarcopenia Muscle | 2018 | https://conductscience.org/library/papers/30144305 | PubMed |
| 2 | 28850803 | High Serum Essential Amino Acids as a Predictor of Skeletal Muscle Depletion in Patients With Cachexia and Advanced Gastrointestinal Cancers. | Nutr Clin Pract | 2017 | https://conductscience.org/library/papers/28850803 | PubMed |
| 3 | 37017344 | GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice. | J Cachexia Sarcopenia Muscle | 2023 | https://conductscience.org/library/papers/37017344 | PubMed |
| 4 | 24415363 | Cancer cachexia update in head and neck cancer: Definitions and diagnostic features. | Head Neck | 2015 | https://conductscience.org/library/papers/24415363 | PubMed |
| 5 | 38519312 | Sarcopenia with decreased total psoas muscle area in children with high-risk neuroblastoma. | Asian J Surg | 2024 | https://conductscience.org/library/papers/38519312 | PubMed |
| 6 | 37902220 | Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy. | Cancer Med | 2023 | https://conductscience.org/library/papers/37902220 | PubMed |
| 7 | 26903572 | Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/26903572 | PubMed |
| 8 | 29089584 | ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass. | Sci Rep | 2017 | https://conductscience.org/library/papers/29089584 | PubMed |
| 9 | 34664403 | Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice. | J Cachexia Sarcopenia Muscle | 2021 | https://conductscience.org/library/papers/34664403 | PubMed |
| 10 | 31999069 | Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer. | J Cachexia Sarcopenia Muscle | 2020 | https://conductscience.org/library/papers/31999069 | PubMed |
| 11 | 33829665 | Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer. | Thorac Cancer | 2021 | https://conductscience.org/library/papers/33829665 | PubMed |
| 12 | 29067769 | Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non-small cell lung cancer. | Thorac Cancer | 2018 | https://conductscience.org/library/papers/29067769 | PubMed |
| 13 | 35931609 | The urgent need to improve childhood cancer cachexia. | Trends Cancer | 2022 | https://conductscience.org/library/papers/35931609 | PubMed |
| 14 | 36615760 | Quercetin Improved Muscle Mass and Mitochondrial Content in a Murine Model of Cancer and Chemotherapy-Induced Cachexia. | Nutrients | 2022 | https://conductscience.org/library/papers/36615760 | PubMed |
| 15 | 29991992 | Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia. | Eur J Transl Myol | 2018 | https://conductscience.org/library/papers/29991992 | PubMed |
| 16 | 33067699 | A Retrospective Cohort Study to Investigate the Incidence of Cachexia During Chemotherapy in Patients with Colorectal Cancer. | Adv Ther | 2020 | https://conductscience.org/library/papers/33067699 | PubMed |
| 17 | 27807421 | Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways. | Front Physiol | 2016 | https://conductscience.org/library/papers/27807421 | PubMed |
| 18 | 21875767 | Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. | Clin Nutr | 2012 | https://conductscience.org/library/papers/21875767 | PubMed |
| 19 | 21296615 | Definition and classification of cancer cachexia: an international consensus. | Lancet Oncol | 2011 | https://conductscience.org/library/papers/21296615 | PubMed |
| 20 | 28882973 | Elevated Serum AA/EPA Ratio as a Predictor of Skeletal Muscle Depletion in Cachexic Patients with Advanced Gastro-intestinal Cancers. | In Vivo | 2017 | https://conductscience.org/library/papers/28882973 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42734427 | 5-Fluorouracil-based chemotherapy disrupts autophagy flux and protein synthesis in cultured myotubes: a role for mTORC1 signaling. | Am J Physiol Cell Physiol | 2026 | https://conductscience.org/library/papers/42734427 | PubMed |
| 42286673 | The cGAS-STING pathway contributes to cisplatin-induced skeletal muscle atrophy through altered proteostasis and myogenic signaling. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42286673 | PubMed |
| 42270763 | Oxaliplatin triggers adipose and muscle wasting through cancer-independent metabolic and CNS pathways in mouse models. | Commun Biol | 2026 | https://conductscience.org/library/papers/42270763 | PubMed |
| 41965808 | Prevalence of ovarian cancer cachexia in patients undergoing cytoreductive surgery at the University of Colorado between 2014-2024. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/41965808 | PubMed |
| 41525266 | Sex differences in cachexia outcomes and branched-chain amino acid metabolism following chemotherapy in aged mice. | PLoS One | 2026 | https://conductscience.org/library/papers/41525266 | PubMed |
| 41369973 | The evolving landscape of cancer cachexia prevention: A review of metronomic chemotherapy and drug repurposing strategies. | Med Oncol | 2025 | https://conductscience.org/library/papers/41369973 | PubMed |
| 41315185 | Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1. | Nat Commun | 2025 | https://conductscience.org/library/papers/41315185 | PubMed |
| 41301412 | Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines. | Biomolecules | 2025 | https://conductscience.org/library/papers/41301412 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39636147
GET https://conductscience.org/api/papers/v1/39636147/references?page=2